Goldman Sachs Global Future Health Care Equity Portfolio Base USD Acc
Equity fund
1 year
USA
Largest region
Medium
Risk
Annual costs
Morningstar
Partial
Sustainability
Development
Last 5 years
Description
- The Portfolio seeks long-term capital appreciation by investing primarily in equity securities of companies that are domiciled anywhere in the world which, in the view of the Investment Adviser, have the potential to be beneficiaries of evolving trends in the health care sector, including, but not limited to, the beneficiaries and drivers of advancements in genomics, precision medicine, life extension and robotic surgery.
Investment horizon
- Goldman Sachs Global Future Health Care Equity Portfolio Base USD Acc is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.
Characteristics
- Minimum amount
- Sharpe 3 years
- Price/NAV
09 Sept 2025
- Start date29 Sept 2020
- ISINLU2220395680
Risk
- Medium (4 of 7)
Morningstar rating
- The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.
Sustainability
- SustainabilityPartial
Annual cost
- Ongoing costs
Includes management fees of 1,50 %
- Platform fee
- Kickback fee
- Annual running costs
Other costs
- Performance-based fee
- Transaction costs
Costs for any currency exchanges are not included.
Allocation
- Stocks 98%Interest 2%
Portfolio
Shows the fund's largest investments.
- Eli Lilly and Co8.9%
- Boston Scientific Corp8.7%
- Abbott Laboratories6.3%
- AbbVie Inc5.5%
- Insulet Corp4.9%
- AstraZeneca PLC4.7%
- Intuitive Surgical Inc4.5%
- Thermo Fisher Scientific Inc3.7%
- Lonza Group Ltd3.4%
- Alnylam Pharmaceuticals Inc3.4%